Pay to Marwadi

Company Profile

SUN PHARMACEUTICAL INDUSTRIES LTD.

NSE : SUNPHARMABSE : 524715ISIN CODE : INE044A01036Industry : Pharmaceuticals & DrugsHouse : Sun Pharma
BSE1520.5534.2 (+2.3 % )
PREV CLOSE (Rs.) 1486.35
OPEN PRICE (Rs.) 1488.45
BID PRICE (QTY) 0.00 (0 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 100135
TODAY'S LOW / HIGH (Rs.)1488.45 1526.55
52 WK LOW / HIGH (Rs.)922.55 1638.7
NSE1520.15 34.4 (+2.32 % )
PREV CLOSE(Rs.) 1485.75
OPEN PRICE (Rs.) 1490.00
BID PRICE (QTY) 1520.15 (1862 )
OFFER PRICE (QTY) 0.00 (0 )
VOLUME 3846327
TODAY'S LOW / HIGH(Rs.) 1488.65 1527.30
52 WK LOW / HIGH (Rs.)922.45 1638.85

Company Profile

Smart Quotes

1D 1M 3M 1Y 3Y 5Y
STOCK SUMMARY
Trade Value (Rs. in Lacs) 0.02
Dividend Yield(%) 0.76
TTM EPS (Rs.) 4.04
P/E Ratio 376.21
Book Value (Rs.) 103.23
Face Value (Rs.) 1
MCap (Rs. in Mn) 3648308.79
Price/Earning (TTM) 140.90
Price/Sales (TTM) 18.14
Price/Book (MRQ) 14.73
PAT Margin (%) 7.77
ROCE (%) 7.28
Incorporation Year : 1993

Management Info :

- Chairman Dilip S Shanghvi - Managing Director

Registered Office :

Address : Sun Pharma Advanced Research Centre (S P A R C),Tandalja,,
Vadodara,
Gujarat-390020

Phone : 0265- 5515500 / 5515600 / 5515700

Website : www.sunpharma.com

Registrar's Details : Link Intime India Pvt Ltd.
C 101, 247 Park,LBS Marg,Vikhroli (West),Mumbai
Listing : BSE, NSE, MCX
NEWS More
25Apr04-25-2024$Pharma stocks jump amid rise in India’s drugs and pharmaceuticals exports in FY24 Pharma stocks jump amid rise

Stocks related to pharmaceuticals industry were trading higher on the BSE, as the commerce ministry in its latest data has showed that the country's drugs and pharmaceuticals exports increased 9.67 per cent year-on-year to $27.9 billion in 2023-24, even as the total exports dipped by 3 per cent in the last fiscal. In March 2024, pharma exports grew by 12.73 per cent to $2.8 billion.

Sun Pharmaceutical Industries is currently trading at Rs. 1499.25, up by 12.90 points or 0.87% from its previous closing of Rs. 1486.35 on the BSE.

Lupin is currently trading at Rs. 1593.00, up by 12.95 points or 0.82% from its previous closing of Rs. 1580.05 on the BSE.

Aurobindo Pharma is currently trading at Rs. 1089.65, up by 6.05 points or 0.56% from its previous closing of Rs. 1083.60 on the BSE.

According to the data, the top five export markets, for the sector during the last fiscal, are the US, the UK, the Netherlands, South Africa and Brazil. The US accounts for over 31 per cent of India's total pharma exports, followed by the UK and Netherlands (about 3 per cent each). In 2023-24, the outbound shipments also entered new geographies like Montenegro, South Sudan, Chad, Comoros, Brunei, Latvia, Ireland, Chad, Sweden, Haiti and Ethiopia.

India's pharmaceutical industry is the third largest by volume and the 13th largest by value in the world, producing more than 60,000 generic drugs across 60 therapeutic categories. The government has rolled out two production-linked incentive (PLI) schemes to promote domestic manufacturing of key pharmaceutical ingredients and generic medicines. 


Stocks related to pharmaceuticals industry were trading higher..
12Apr04-12-2024$USFDA issues OAI status to Sun Pharmaceutical Industries’ Dadra facility USFDA issues OAI status to S

US Food and Drug Administration (USFDA) has issued Official Action Indicated (OAI) status to Sun Pharmaceutical Industries’ Dadra facility. USFDA conducted an inspection at Company’s Dadra facility from December 4, 2023 to December 15, 2023. The company will work with the regulator to achieve fully compliant status. 

Sun Pharmaceutical Industries is among the largest specialty generic pharmaceutical company and India's top pharmaceutical company.

US Food and Drug Administration (USFDA) has issued Official Act..
28Mar03-28-2024$ Clarification sought from Sun Pharmaceutical Industries Ltd Clarification sought from S
The Exchange has sought clarification from Sun Pharmaceutical Industries Ltd on March 28, 2024, with reference to Movement in Volume. The reply is awaited.
The Exchange has sought clarification from Sun Pharmaceutical I..
23Mar03-23-2024$Sun Pharmaceutical Industries informs about details of loss of certificate Sun Pharmaceutical Industrie
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, Sun Pharmaceutical Industries has informed about details of loss of share certificate reported by shareholder of the Company. Name of the Shareholder: Hasmukh Bhai Patel, Folio No 008048. The Company will duly issue letter of confirmations in lieu of original share certificate.

The above information is a part of company’s filings submitted to BSE.
Pursuant to Regulation 39(3) of the SEBI (Listing Obligations a..
19Mar03-19-2024$Sun Pharmaceutical Industries informs about press release Sun Pharmaceutical Industrie
Sun Pharmaceutical Industries has informed that it enclosed a copy of the Press Release relating to Australian Therapeutic Goods Administration (TGA) approval for Winlevi®, which shall be released after this intimation.

The above information is a part of company’s filings submitted to BSE. 

Sun Pharmaceutical Industries has informed that it enclosed a c..
Financials More
Rs. in Millions
QTR Dec 23 ANNUAL 23
Net Profit7213.116907.2
Gross Profit 7514.7 17410.5
Operating Profit 1435867518.9
Net Sales 50737.5208121.4
ROLLING FORWARD P/E (EOD)
EVENT CALENDAR
peer group More
Dr. Reddy's Lab (BSE)
 6217.15 (4.47%)
M.Cap ( in Cr)
103713.42
Abbott India (BSE)
 25725.00 (1.03%)
M.Cap ( in Cr)
54663.83
Bharat Parenterals (BSE)
 1701.80 (10.00%)
M.Cap ( in Cr)
990.39
Alkem Laboratories (BSE)
 4857.90 (3.10%)
M.Cap ( in Cr)
58083.48
NGL Fine-Chem (BSE)
 2711.85 (3.47%)
M.Cap ( in Cr)
1675.39
Shareholding Pattern More
NON-INSTITUTION 8.97 %
PROMOTERS 54.48 %
FI/BANKS/INSURANCE 5.12 %
MUTUAL FUNDS/UTI 12.21 %
GOVERNMENT 0 %
FII 0 %
MF HOLDINGS More
F & O Quotes